EHF and triple-negative breast carcinoma: Using overexpression and knockdown approaches, recent studies have shown that EHF has a tumor suppressor role in triple negative breast cancer cells via inhibition of epithelial-mesenchymal transition (EMT) and metastasis while sensitizing cells to chemotherapy and inducing apoptosis [79, 80].